Oxford Biodynamics Business

Our proprietary technology platform enables pharmaceutical companies to accelerate and improve the rate of drug discovery and development

Through the development of epigenetic biomarkers, EpiSwitch™ can help pharmaceutical companies to:

  • REDUCE the risk, cost and time to market for therapeutic development programmes
  • GAIN significant insights into disease mechanisms, to support the personalisation of medicine
  • PERSONALISE therapeutics to patients, to ensure better clinical outcomes

Oxford Biodynamics PLC (LON:OBD) was spun out from Oxford University in June 2007 with the aim of translating fundamental scientific advances into a commercialised platform technology and a new generation of biomarkers for cancer, ALS and other diseases.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Oxford BioDynamics

    More articles like this

    Oxford BioDynamics

    FDA publishes guidance to help in developing new ALS therapies

    After gathering input from patients, researchers, and advocates, the U.S Food and Drug Administration (FDA) has released new guidance on the development of therapies for amyotrophic lateral sclerosis (ALS). Among its recommendations, it is advising more communication with

    Oxford BioDynamics

    Qualtrax Boosts Oxford BioDynamics Efficiencies

    Businesses involved in areas such as the pharmaceutical sector must demonstrate the highest levels of compliance, traceability and quality. Given the large volumes of documents generated by such organisations, important tasks such as keeping track of

    Oxford BioDynamics

    What you need to know about rheumatoid arthritis

    Rheumatoid arthritis (RA) is a chronic disease that affects the joints throughout your body. It often starts in the hands and feet RA is an autoimmune disease, it happens when your immune system attacks your own cells. While

    Oxford BioDynamics

    Want to Slow Down Your ALS? Try Smiling!

    What does smiling have to do with ALS? Or happiness, contentment, or feeling positive? These expressions of our sense of well-being are important to those of us living with ALS. According to a study of 224 ALS patients, participants

    Oxford BioDynamics

    How does alcohol affect rheumatoid arthritis?

    Drinking alcohol in moderation is typically safe for people with rheumatoid arthritis (RA). According to the Arthritis Foundation, drinking alcohol in moderation is usually safe, and may even reduce certain types of inflammation. Some research says that small

    Oxford BioDynamics

    Ice Bucket Challenge Creator Continues To Inspire

    A Westchester man battling ALS is fighting for a cure and one way he hopes to do that is by bringing back the ice bucket challenge. Pat Quinn was diagnosed with the deadly degenerative disease in

    Oxford BioDynamics

    MND Association welcomes report on benefits and terminal illness

    A report revealing terminally ill people face devastating and far-reaching financial hardship because of a ‘made-up policy fudge’ has been welcomed by the Motor Neurone Disease (MND) Association. The All Party Parliamentary Group for Terminal Illness

    Oxford BioDynamics

    Having this temperature in your joints must NOT be ignored

    Arthritis is a type of inflammatory autoimmune disease and is a musculoskeletal condition which is caused by the body’s joints. The areas most commonly affected include the hands, fingers, hips, knees and spine. The disease commonly affects